Sign in
4

Changes in Ownership

REGENERON PHARMACEUTICALS, INC. Filed Acc 0001708138-20-000102

Director sold 33,750 shares at an average $607.42 ($20,500,518)

  • Director acquired 12,750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

SING GEORGE L · Director

Table I: Non-derivative

17 lines
Date Transaction Shares Price Value Owned after D/I
2020-08-25 Exercise or conversion : show line 1 in the form +12,750 $273.67 $3,489,293 97,165 D
2020-08-25 Sale : show line 2 in the form −1,400 $600.36 $840,504 95,765 D
2020-08-25 Sale : show line 3 in the form −300 $601.75 $180,525 95,465 D
2020-08-25 Sale : show line 4 in the form −400 $602.68 $241,072 95,065 D
2020-08-25 Sale : show line 5 in the form −3,000 $603.53 $1,810,590 92,065 D
2020-08-25 Sale : show line 6 in the form −3,705 $604.43 $2,239,413 88,360 D
2020-08-25 Sale : show line 7 in the form −4,700 $605.53 $2,845,991 83,660 D
2020-08-25 Sale : show line 8 in the form −5,168 $606.43 $3,134,030 78,492 D
Open-market sales · 33,750 sh · avg $607.42 · $20,500,518

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-08-25 Exercise or conversion : show line 18 in the form Non-Qualified Stock Option (right to buy) −12,750 $273.67 2024-01-02 12,750 0 D
Loading xslF345X03/edgardoc.xml…